\-\ Texto\\:\\ \ \(0\)\
\-\ mental\\ status\\ exam\\ confounded\\ by\\ difficulty\\ hearing\\ and\\ following\\ directions\\.\\ \\ vision\\ unable\\ to\\ be\\ assessed\\ due\\ to\\ severe\\ cataracts\\.\\ \\ left\\ corner\\ of\\ mouth\\ drooping\\,\\ left\\ eye\\ ptosis\\.\\ \\ ms\\:\\ lue\\ flaccid\\,\\ finger\\ flexors\\ \\+clonus\\,\\ \\+hoffmann\\'s\\ sign\\.\\ lle\\ w\\/some\\ spontaneous\\ movement\\,\\ unable\\ to\\ lift\\ to\\ gravity\\.\\ dtrs\\ 2\\+\\ throughout\\ biceps\\,\\ brachioradialis\\,\\ knee\\,\\ patellar\\.\\ babinski\\'s\\ upgoing\\ bilaterally\\.\ \(0\)\
\-\ inr\\ 1\\.2\ \(0\)\
\-\ treatment\\ consisted\\ of\\ reaching\\ therapeutic\\ level\\ of\\ anticoagulation\\ with\\ an\\ inr\\ of\\ 3\\.0\\ and\\ movement\\ to\\ a\\ skilled\\ nursing\\ facility\\ for\\ an\\ unknown\\ duration\\.\\ \\ if\\ patient\\ able\\ to\\ regain\\ ability\\ to\\ ambulate\\ and\\ the\\ cognitive\\ deficits\\ do\\ not\\ persist\\,\\ then\\ he\\ may\\ be\\ able\\ to\\ return\\ home\\ with\\ some\\ amount\\ of\\ home\\ health\\ care\\.\ \(0\)\
\-\ a\\ new\\ large\\ area\\ of\\ restricted\\ diffusion\\ in\\ the\\ right\\ posterior\\ cerebral\\ artery\\ territory\\ involving\\ the\\ parasagittal\\ right\\ parietal\\ and\\ right\\ occipital\\ regions\\.\\ \\ numerous\\ areas\\ of\\ periventricular\\ and\\ deep\\ white\\ matter\\ intensities\\ on\\ the\\ dwi\\ are\\ not\\ present\\ on\\ the\\ adc\\ map\\.\\ \\ this\\ represents\\ probable\\ t2\\ shine\\-through\\ corresponding\\ to\\ diffuse\\ chronic\\ microvascular\ \(0\)\
\-\ ischemic\\ changes\\.\ \(9\)\
\-\ posterior\\ cerebral\\ artery\\ infarction\ \(0\)\
\-\ \\â\\€\\¢\\ ischemia\\ \\(with\\ or\\ without\\ infarction\\ in\\ the\\ pca\\ distribution\\)\ \(0\)\
\-\ \\â\\€\\¢\\ hyperemia\\ with\\ migraine\ \(0\)\
\-\ \\â\\€\\¢\\ hyperemia\\ after\\ seizure\ \(0\)\
\-\ \\â\\€\\¢\\ encephalitis\\ \\(hsv\\ or\\ other\\)\ \(0\)\
\-\ \\â\\€\\¢\\ meningitis\ \(2\)\
\-\ \\â\\€\\¢\\ hypertensive\\ encephalopathy\ \(0\)\
\-\ elderly\\ \\(\\>89\\ y\\.o\\.\\)\\ man\\ with\\ 15\\ year\\ history\\ of\\ htn\\ and\\ atrial\\ fibrillation\\ presents\\ with\\ decreased\\ alertness\\ and\\ responsiveness\\ x\\ 3\\ hours\\,\\ which\\ has\\ resolved\\ on\\ presentation\\.\\ \\ \ \(0\)\
\-\ pt\\ had\\ several\\ episodes\\ of\\ l\\ sided\\ lower\\ extremity\\ weakness\\ and\\ facial\\ drooping\\ lasting\\ from\\ minutes\\ to\\ hours\\ over\\ the\\ past\\ several\\ months\\.\\ \\ after\\ one\\ of\\ these\\ episodes\\,\\ he\\ was\\ admitted\\ with\\ concern\\ over\\ his\\ ability\\ to\\ manage\\ his\\ own\\ medications\\.\\ \\ his\\ coumadin\\ was\\ discontinued\\ and\\ he\\ was\\ and\\ placed\\ on\\ antiplatelet\\ medication\\ alone\\,\\ due\\ to\\ the\\ potential\\ for\\ falls\\ and\\ subsequent\\ bleeds\\.\ \(0\)\
\-\ this\\ case\\ demonstrates\\ the\\ importance\\ of\\ carefully\\ weighing\\ the\\ risk\\/benefit\\ ratio\\ of\\ anticoagulating\\ patients\\ with\\ atrial\\ fibulation\\.\\ \\ also\\,\\ it\\ illustrates\\ the\\ importance\\ and\\ relevance\\ of\\ comparing\\ dwi\\ and\\ adc\\ map\\ images\\ in\\ the\\ assessment\\ of\\ acute\\ cerebral\\ infarction\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ drooping\\:\\ 0\\.037641689177595535\ \(0\)\
\-\ hyperemia\\:\\ 0\\.03136699161977086\ \(0\)\
\-\ map\\:\\ 0\\.03024483045458723\ \(0\)\
\-\ inr\\:\\ 0\\.029313876828311075\ \(0\)\
\-\ infarction\\:\\ 0\\.028705548861600736\ \(0\)\
\-\ ability\\:\\ 0\\.028518358966149446\ \(0\)\
\-\ adc\\:\\ 0\\.02795587045075173\ \(0\)\
\-\ importance\\:\\ 0\\.027325353575218647\ \(0\)\
\-\ \\â\\€\\¢\\:\\ 0\\.025759140026233772\ \(0\)\
\-\ dwi\\:\\ 0\\.02487042358876955\ \(0\)\
\-\ cerebral\\:\\ 0\\.02433243700080058\ \(0\)\
\-\ \\+clonus\\:\\ 0\\.024152105271141092\ \(0\)\
\-\ \\+hoffmann\\:\\ 0\\.024152105271141092\ \(0\)\
\-\ w\\/some\\:\\ 0\\.024152105271141092\ \(0\)\
\-\ shine\\-through\\:\\ 0\\.024152105271141092\ \(0\)\
\-\ alertness\\:\\ 0\\.024152105271141092\ \(0\)\
\-\ risk\\/benefit\\:\\ 0\\.024152105271141092\ \(0\)\
\-\ anticoagulating\\:\\ 0\\.024152105271141092\ \(0\)\
\-\ fibulation\\:\\ 0\\.024152105271141092\ \(0\)\
\-\ atrial\\:\\ 0\\.02396091598617086\ \(0\)\
\-\ movement\\:\\ 0\\.023409444612035587\ \(0\)\
\-\ episodes\\:\\ 0\\.023125471637435117\ \(0\)\
\-\ home\\:\\ 0\\.022257141001973336\ \(0\)\
\-\ regain\\:\\ 0\\.02225307189974398\ \(0\)\
\-\ able\\:\\ 0\\.022071379074983303\ \(0\)\
\-\ unable\\:\\ 0\\.021632788895950224\ \(0\)\
\-\ confounded\\:\\ 0\\.0211422085898586\ \(0\)\
\-\ flaccid\\:\\ 0\\.0211422085898586\ \(0\)\
\-\ upgoing\\:\\ 0\\.0211422085898586\ \(0\)\
\-\ skilled\\:\\ 0\\.0211422085898586\ \(0\)\
\-\ responsiveness\\:\\ 0\\.0211422085898586\ \(0\)\
\-\ antiplatelet\\:\\ 0\\.0211422085898586\ \(0\)\
\-\ relevance\\:\\ 0\\.0211422085898586\ \(0\)\
\-\ cataracts\\:\\ 0\\.02035403852834687\ \(0\)\
\-\ his\\:\\ 0\\.020242923514906287\ \(0\)\
\-\ lue\\:\\ 0\\.019742686332965474\ \(0\)\
\-\ he\\:\\ 0\\.01959606034547687\ \(0\)\
\-\ parasagittal\\:\\ 0\\.01845500515694976\ \(0\)\
\-\ hours\\:\\ 0\\.01841204004717149\ \(0\)\
\-\ microvascular\\:\\ 0\\.018132311908576105\ \(0\)\
\-\ manage\\:\\ 0\\.018132311908576105\ \(0\)\
\-\ flexors\\:\\ 0\\.017843652961568365\ \(0\)\
\-\ brachioradialis\\:\\ 0\\.017843652961568365\ \(0\)\
\-\ bleeds\\:\\ 0\\.017843652961568365\ \(0\)\
\-\ directions\\:\\ 0\\.01758252918128254\ \(0\)\
\-\ lle\\:\\ 0\\.01758252918128254\ \(0\)\
\-\ lift\\:\\ 0\\.01758252918128254\ \(0\)\
\-\ comparing\\:\\ 0\\.01758252918128254\ \(0\)\
\-\ dtrs\\:\\ 0\\.01712484675754784\ \(0\)\
\-\ intensities\\:\\ 0\\.01712484675754784\ \(0\)\
\-\ lasting\\:\\ 0\\.01712484675754784\ \(0\)\
\-\ corner\\:\\ 0\\.016921811217400655\ \(0\)\
\-\ gravity\\:\\ 0\\.016921811217400655\ \(0\)\
\-\ nursing\\:\\ 0\\.016921811217400655\ \(0\)\
\-\ pca\\:\\ 0\\.016921811217400655\ \(0\)\
\-\ hsv\\:\\ 0\\.016921811217400655\ \(0\)\
\-\ babinski\\:\\ 0\\.01673278965168298\ \(0\)\
\-\ ambulate\\:\\ 0\\.01673278965168298\ \(0\)\
\-\ discontinued\\:\\ 0\\.01673278965168298\ \(0\)\
\-\ consisted\\:\\ 0\\.01638987693126105\ \(0\)\
\-\ reaching\\:\\ 0\\.01638987693126105\ \(0\)\
\-\ 89\\:\\ 0\\.01638987693126105\ \(0\)\
\-\ carefully\\:\\ 0\\.01638987693126105\ \(0\)\
\-\ assessed\\:\\ 0\\.016233278537178996\ \(0\)\
\-\ ptosis\\:\\ 0\\.016233278537178996\ \(0\)\
\-\ weighing\\:\\ 0\\.016233278537178996\ \(0\)\
\-\ territory\\:\\ 0\\.015810947907515274\ \(0\)\
\-\ cognitive\\:\\ 0\\.015561710159006434\ \(0\)\
\-\ persist\\:\\ 0\\.015122415227293615\ \(0\)\
\-\ migraine\\:\\ 0\\.015122415227293615\ \(0\)\
\-\ several\\:\\ 0\\.015052563483410343\ \(0\)\
\-\ own\\:\\ 0\\.015022777846003546\ \(0\)\
\-\ fibrillation\\:\\ 0\\.01483375628028587\ \(0\)\
\-\ coumadin\\:\\ 0\\.01483375628028587\ \(0\)\
\-\ 1\\.2\\:\\ 0\\.014743921149263978\ \(0\)\
\-\ falls\\:\\ 0\\.014656938414155538\ \(0\)\
\-\ 3\\.0\\:\\ 0\\.014490843559863936\ \(0\)\
\-\ illustrates\\:\\ 0\\.014186115792438664\ \(0\)\
\-\ to\\:\\ 0\\.01404059534607078\ \(0\)\
\-\ artery\\:\\ 0\\.013942630093743556\ \(0\)\
\-\ hypertensive\\:\\ 0\\.013847447419925852\ \(0\)\
\-\ encephalopathy\\:\\ 0\\.013784462438488321\ \(0\)\
\-\ elderly\\:\\ 0\\.013784462438488321\ \(0\)\
\-\ periventricular\\:\\ 0\\.013489583906454442\ \(0\)\
\-\ probable\\:\\ 0\\.013489583906454442\ \(0\)\
\-\ biceps\\:\\ 0\\.013223381855896504\ \(0\)\
\-\ mouth\\:\\ 0\\.013173110243106924\ \(0\)\
\-\ therapeutic\\:\\ 0\\.013173110243106924\ \(0\)\
\-\ encephalitis\\:\\ 0\\.013075252482553283\ \(0\)\
\-\ health\\:\\ 0\\.012980769808385695\ \(0\)\
\-\ ratio\\:\\ 0\\.012980769808385695\ \(0\)\
\-\ htn\\:\\ 0\\.01288943715011832\ \(0\)\
\-\ facility\\:\\ 0\\.012801051226232783\ \(0\)\
\-\ alone\\:\\ 0\\.012673599128602938\ \(0\)\
\-\ assessment\\:\\ 0\\.012591810188466826\ \(0\)\
\-\ ms\\:\\ 0\\.012512392279225038\ \(0\)\
\-\ due\\:\\ 0\\.012494669331248437\ \(0\)\
\-\ patellar\\:\\ 0\\.012435211794384775\ \(0\)\
\-\ finger\\:\\ 0\\.01239742187073454\ \(0\)\
\-\ duration\\:\\ 0\\.01239742187073454\ \(0\)\
\-\ meningitis\\:\\ 0\\.012146552847377031\ \(0\)\
\-\ minutes\\:\\ 0\\.012112518546011121\ \(0\)\
\-\ 2\\+\\:\\ 0\\.01198045799308543\ \(0\)\
\-\ over\\:\\ 0\\.01192132926104089\ \(0\)\
\-\ corresponding\\:\\ 0\\.011916740562498397\ \(0\)\
\-\ return\\:\\ 0\\.011854471381463996\ \(0\)\
\-\ anticoagulation\\:\\ 0\\.011823859599003379\ \(0\)\
\-\ medication\\:\\ 0\\.011793586075204516\ \(0\)\
\-\ concern\\:\\ 0\\.011647041732873047\ \(0\)\
\-\ hearing\\:\\ 0\\.011535200651995635\ \(0\)\
\-\ ischemic\\:\\ 0\\.011401528969339658\ \(0\)\
\-\ resolved\\:\\ 0\\.011349834491793402\ \(0\)\
\-\ potential\\:\\ 0\\.011274076871709813\ \(0\)\
\-\ represents\\:\\ 0\\.011249282801792231\ \(0\)\
\-\ mental\\:\\ 0\\.01092384845661424\ \(0\)\
\-\ spontaneous\\:\\ 0\\.01092384845661424\ \(0\)\
\-\ occipital\\:\\ 0\\.01092384845661424\ \(0\)\
\-\ ischemia\\:\\ 0\\.010880359828788787\ \(0\)\
\-\ vision\\:\\ 0\\.010816394447975112\ \(0\)\
\-\ posterior\\:\\ 0\\.01079253999289013\ \(0\)\
\-\ restricted\\:\\ 0\\.010774565757205829\ \(0\)\
\-\ deficits\\:\\ 0\\.010712996289117996\ \(0\)\
\-\ regions\\:\\ 0\\.010712996289117996\ \(0\)\
\-\ l\\:\\ 0\\.010672705474351708\ \(0\)\
\-\ distribution\\:\\ 0\\.010536178422987664\ \(0\)\
\-\ numerous\\:\\ 0\\.01049838849933743\ \(0\)\
\-\ diffusion\\:\\ 0\\.01047968722517195\ \(0\)\
\-\ medications\\:\\ 0\\.010442663337043943\ \(0\)\
\-\ difficulty\\:\\ 0\\.010424337342110254\ \(0\)\
\-\ seizure\\:\\ 0\\.010352235127542108\ \(0\)\
\-\ \\'s\\:\\ 0\\.010323543114339973\ \(0\)\
\-\ facial\\:\\ 0\\.010179868482581643\ \(0\)\
\-\ do\\:\\ 0\\.010163213561824432\ \(0\)\
\-\ admitted\\:\\ 0\\.010113847793323943\ \(0\)\
\-\ parietal\\:\\ 0\\.010002006712446533\ \(0\)\
\-\ eye\\:\\ 0\\.009820300841402497\ \(0\)\
\-\ amount\\:\\ 0\\.009776696854263047\ \(0\)\
\-\ after\\:\\ 0\\.009687677822516177\ \(0\)\
\-\ deep\\:\\ 0\\.009476526436423249\ \(0\)\
\-\ placed\\:\\ 0\\.009476526436423249\ \(0\)\
\-\ 15\\:\\ 0\\.009337936034264053\ \(0\)\
\-\ matter\\:\\ 0\\.009217753343563829\ \(0\)\
\-\ unknown\\:\\ 0\\.009136656166094539\ \(0\)\
\-\ subsequent\\:\\ 0\\.009113919720026882\ \(0\)\
\-\ \\,\\:\\ 0\\.008900056948513558\ \(0\)\
\-\ throughout\\:\\ 0\\.008763691304931306\ \(0\)\
\-\ pt\\:\\ 0\\.008704558231870555\ \(0\)\
\-\ weakness\\:\\ 0\\.0086948256247353\ \(0\)\
\-\ sided\\:\\ 0\\.008656237296292179\ \(0\)\
\-\ extremity\\:\\ 0\\.008562079368883391\ \(0\)\
\-\ knee\\:\\ 0\\.008489015678247332\ \(0\)\
\-\ care\\:\\ 0\\.008444320950873295\ \(0\)\
\-\ status\\:\\ 0\\.008357061153922339\ \(0\)\
\-\ then\\:\\ 0\\.008331416105266\ \(0\)\
\-\ involving\\:\\ 0\\.008214814421926833\ \(0\)\
\-\ new\\:\\ 0\\.008158323224111119\ \(0\)\
\-\ was\\:\\ 0\\.008122828949701535\ \(0\)\
\-\ sign\\:\\ 0\\.008110812333600195\ \(0\)\
\-\ presentation\\:\\ 0\\.008064111327372829\ \(0\)\
\-\ on\\:\\ 0\\.007933052190306062\ \(0\)\
\-\ areas\\:\\ 0\\.007877663482865936\ \(0\)\
\-\ \\>\\:\\ 0\\.007778541136078259\ \(0\)\
\-\ white\\:\\ 0\\.007764669075923336\ \(0\)\
\-\ x\\:\\ 0\\.007723469411910896\ \(0\)\
\-\ bilaterally\\:\\ 0\\.007689603393216174\ \(0\)\
\-\ past\\:\\ 0\\.007438902662866943\ \(0\)\
\-\ right\\:\\ 0\\.007410671581729452\ \(0\)\
\-\ area\\:\\ 0\\.00740229107981991\ \(0\)\
\-\ be\\:\\ 0\\.007220584785446187\ \(0\)\
\-\ severe\\:\\ 0\\.007203588493331518\ \(0\)\
\-\ some\\:\\ 0\\.007109392476347285\ \(0\)\
\-\ diffuse\\:\\ 0\\.007087691562672096\ \(0\)\
\-\ decreased\\:\\ 0\\.006960976445820711\ \(0\)\
\-\ not\\:\\ 0\\.006766129708174988\ \(0\)\
\-\ y\\.o\\:\\ 0\\.006757203924895069\ \(0\)\
\-\ level\\:\\ 0\\.00674764117163543\ \(0\)\
\-\ changes\\:\\ 0\\.006709720482835782\ \(0\)\
\-\ following\\:\\ 0\\.0066445965942497215\ \(0\)\
\-\ t2\\:\\ 0\\.006626270599316033\ \(0\)\
\-\ chronic\\:\\ 0\\.006594492144950685\ \(0\)\
\-\ an\\:\\ 0\\.006474875968683451\ \(0\)\
\-\ and\\:\\ 0\\.006411279656216\ \(0\)\
\-\ months\\:\\ 0\\.006394359711479636\ \(0\)\
\-\ if\\:\\ 0\\.006352721736385303\ \(0\)\
\-\ one\\:\\ 0\\.0063444695433168335\ \(0\)\
\-\ these\\:\\ 0\\.006092725183446137\ \(0\)\
\-\ patients\\:\\ 0\\.00605910849141377\ \(0\)\
\-\ \\(\\:\\ 0\\.005937219667757757\ \(0\)\
\-\ \\)\\:\\ 0\\.0058646933598353835\ \(0\)\
\-\ acute\\:\\ 0\\.005780491312620535\ \(0\)\
\-\ man\\:\\ 0\\.0055367995701095865\ \(0\)\
\-\ without\\:\\ 0\\.005512364839337426\ \(0\)\
\-\ or\\:\\ 0\\.005487795884732644\ \(0\)\
\-\ 3\\:\\ 0\\.005482124730702849\ \(0\)\
\-\ other\\:\\ 0\\.005396269996445065\ \(0\)\
\-\ present\\:\\ 0\\.00528769521625118\ \(0\)\
\-\ this\\:\\ 0\\.0052665052784336055\ \(0\)\
\-\ lower\\:\\ 0\\.005265375532503733\ \(0\)\
\-\ it\\:\\ 0\\.005262598313789087\ \(0\)\
\-\ left\\:\\ 0\\.005238932982317341\ \(0\)\
\-\ exam\\:\\ 0\\.005143106684793255\ \(0\)\
\-\ may\\:\\ 0\\.0051351462161592434\ \(0\)\
\-\ case\\:\\ 0\\.005121929953061015\ \(0\)\
\-\ large\\:\\ 0\\.00511929433378378\ \(0\)\
\-\ demonstrates\\:\\ 0\\.005114030689460784\ \(0\)\
\-\ had\\:\\ 0\\.005051643340385502\ \(0\)\
\-\ presents\\:\\ 0\\.004782587110980619\ \(0\)\
\-\ treatment\\:\\ 0\\.004738676601646266\ \(0\)\
\-\ also\\:\\ 0\\.004615396147041511\ \(0\)\
\-\ the\\:\\ 0\\.0045451819628589294\ \(0\)\
\-\ images\\:\\ 0\\.004491133950546175\ \(0\)\
\-\ of\\:\\ 0\\.004468638934717365\ \(0\)\
\-\ has\\:\\ 0\\.004396438275326789\ \(0\)\
\-\ which\\:\\ 0\\.00437025914313027\ \(0\)\
\-\ for\\:\\ 0\\.003995113143247754\ \(0\)\
\-\ by\\:\\ 0\\.0038982764472462322\ \(0\)\
\-\ from\\:\\ 0\\.0034696868853540063\ \(0\)\
\-\ in\\:\\ 0\\.0034635388778651087\ \(0\)\
\-\ history\\:\\ 0\\.0032334644868687217\ \(0\)\
\-\ are\\:\\ 0\\.0031914352672043882\ \(0\)\
\-\ \\:\\:\\ 0\\.003096643331481274\ \(0\)\
\-\ year\\:\\ 0\\.0026194664911586706\ \(0\)\
\-\ with\\:\\ 0\\.002564475092381145\ \(0\)\
\-\ patient\\:\\ 0\\.002346827207990104\ \(0\)\
\-\ a\\:\\ 0\\.0021731495990060345\ \(0\)\
\-\ \\.\\:\\ 0\\.001847921057122135\ \(0\)\
